SCHEMBL2908467

SCHEMBL2908467

COc1cc(Cl)ccc1-c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1C(=O)NCCNS(=O)(=O)c1cccc(C#N)c1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.35
GSK3A P49840 3/20 0.35
SCN9A Q15858 2/20 0.35
CDK1 P06493 2/20 0.33
MEN1 O00255 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CCNB2 O95067 1/20 0.32
CCNB1 P14635 1/20 0.32
CCNB3 Q8WWL7 1/20 0.32
NLRP3 Q96P20 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2913441 0.94 GSK3B (0.37) GSK3BGSK3ACDK1CYP2C9CYP2C19
SCHEMBL2905318 0.92 ATM (0.40) GSK3BGSK3ACDK1ATML3MBTL1
SCHEMBL2909817 0.90 GSK3B (0.36) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2907935 0.87 GSK3B (0.40) GSK3BGSK3ACDK1MEN1CYP2C9
SCHEMBL2908168 0.84 GSK3B (0.42) GSK3BGSK3ACDK1MEN1CYP2C19
SCHEMBL2904027 0.84 GSK3B (0.42) GSK3BGSK3ACDK1MEN1CYP2C19
SCHEMBL2911032 0.80 GSK3B (0.45) GSK3BGSK3ACDK1SMN1; SMN2L3MBTL1
SCHEMBL2903805 0.78 GSK3B (0.41) GSK3BGSK3ACDK1MEN1KMT2A
SCHEMBL2909914 0.78 GSK3B (0.43) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2912130 0.77 GSK3B (0.48) GSK3BGSK3ACDK1MEN1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed